Journals / Haydarpaşa Numune Medical Journal / 2022 / Cilt: 62 - Sayı: 2

Treatment of Craniotomy-Related Bone Flap Osteomyelitis

Pages
162–167
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

BFO treatment becomes more complicated especially due to the close anatomical relation between the frontal and pterional craniotomies and the sinuses.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Cranial bone flap osteomyelitis (BFO) is rare.
📊
Key Findings & Data:Methods: Forty-four BFO cases that developed secondary to 4582 neurosurgical operations carried out in our clinic between 2011 and 2018 were evaluated.
💡
Conclusion & Impact:BFO treatment becomes more complicated especially due to the close anatomical relation between the frontal and pterional craniotomies and the sinuses.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: Cranial bone flap osteomyelitis (BFO) is rare. A few publications relating to postoperative osteomyelitis are available in the literature. In this study, we aim to share our experiences with the clinical management of BFO cases that developed secondary to surgery in the name of contributing to the literature. Methods: Forty-four BFO cases that developed secondary to 4582 neurosurgical operations carried out in our clinic between 2011 and 2018 were evaluated. Patients were investigated in terms of demographic attributes, pathogen microorganisms, time that lapsed between the first surgery and development of osteomyelitis, and the cause of the primary surgery. Clinical procedures of patients who developed BFO and were treated by preserving or discarding the bone flap (BF) were studied retrospectively. Results: A total of 44 patients were followed up due to BFO in our clinic between the years 2011 and 2018. Diagnoses before the first operation were tumor in 18 patients (40.9%), anterior circulation aneurysm in 11 patients (25%), epidural hematoma in 10 patients (22.7%), and chronic subdural haematoma in 5 patients. Regarding to the growth of the culture, microorganisms were grown in 31 cases (31/44) (70.4%) and it could not be grown in culture in 13 patients (13/44) (29.6%). Twenty patients (20/44) (45%) in the study group were treated by debridement+wound irrigation and preserving the BF with antibiotherapy. BF of the remaining 24 patients, on the other hand, were discarded. Discussion and Conclusion: Surgery-associated osteomyelitis is one of the most undesired complications. BFs are discarded in nearly half of the patients, although the pathogen microorganism is isolated in a great majority of the cases and the appropriate antibiotherapy is applied. BFO treatment becomes more complicated especially due to the close anatomical relation between the frontal and pterional craniotomies and the sinuses.

🔖

Cite This Article

CAN, M., AÇIK, V., OLGUNER, S. K., İŞTEMEN, İ., ÖKTEN, A. İ., SARAÇ, M. E. (2022). Treatment of Craniotomy-Related Bone Flap Osteomyelitis. Haydarpaşa Numune Medical Journal, Cilt: 62 - Sayı: 2, 162–167. https://ajindex.com/articles/535850

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Dashti SR, Baharvahdat H, Spetzler RF, Sauvageau E, Chang SW, Stiefel MF, et al. Operative intracranial infection following craniotomy. Neurosurg Focus 2008;24:E10
  2. McClelland S 3rd, Hall WA. Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 2007;45:55–9
  3. Valentini LG, Casali C, Chatenoud L, Chiaffarino F, UbertiFoppa C, Broggi G. Surgical site infections after elective neurosurgery: A survey of 1747 patients. Neurosurgery 2008;62:88– 96
  4. Bani Sadr A, Gregoire B, Tordo J, Guyotat J, Boibieux A, Janier M. Potential utility of bone scan in cranial bone flap osteomyelitis. Ann Nucl Med 2019;33:424–33
  5. Baumeister S, Peek A, Friedman A, Levin LS, Marcus JR. Management of postneurosurgical bone flap loss caused by infection. Plast Reconstr Surg 2008;122:195e–208e
  6. Bruce JN, Bruce SS. Preservation of bone flaps in patients with postcraniotomy infections. J Neurosurg 2003;98:1203–7
  7. Akhaddar A. Cranial osteomyelitis: The old enemy is back. World Neurosurg 2018;115:475–6
  8. Mortazavi MM, Khan MA, Quadri SA, Suriya SS, Fahimdanesh KM, Fard SA, et al. Cranial osteomyelitis: Acomprehensive review of modern therapies. World Neurosurg 2018;111:142–53
  9. Karhade AV, Cote DJ, Larsen AM, Smith TR. Neurosurgical infection rates and risk factors: A national surgical quality improvement program analysis of 132,000 patients, 2006-2014. World Neurosurg 2017;97:205–12
  10. Lopez J, Zhong SS, Sankey EW, Swanson EW, Susarla H, JusueTorres I, et al. Time interval reduction for delayed implantbased cranioplasty reconstruction in the setting of previous bone flap osteomyelitis. Plast Reconstr Surg 2016;137:394e– 404e
  11. Bhaskar IP, Inglis TJ, Lee GY. Clinical, radiological, and microbiological profile of patients with autogenous cranioplasty infections. World Neurosurg 2014;82:e531–4
  12. Korinek AM. Risk factors for neurosurgical site infections after craniotomy: A prospective multicenter study of 2944 patients. The french study group of neurosurgical infections, the SEHP, and the C-CLIN Paris-Nord. Service epidémiologie hygiène et prévention. Neurosurgery 1997;41:1073–81
  13. Erman T, Demirhindi H, Göçer AI, Tuna M, Ildan F, Boyar B. Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis. Surg Neurol 2005;63:107–13
  14. Abu Hamdeh S, Lytsy B, Ronne-Engström E. Surgical site infections in standard neurosurgery procedures- a s